Bruker schedules third-quarter results, putting Bruker stock to the test
Published on 10/25/2026 at 02:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSThe report cycle takes shape
- Bruker announced third-quarter results for November 4, 2026.
- Second-quarter revenue was USD 838.5 million, up 5.20 percent year over year.
- Bruker had a USD 8.8 billion market capitalization as of October 23, 2026.
Bruker Corporation (ISIN US1167941087) will report its third-quarter 2026 results before market opening on November 4, 2026, according to MarketScreener on October 20, 2026. The date puts the next operating update ahead of a market that has already weighed recent analyst changes and second-quarter figures.
Revenue sets the baseline
MarketBeat reported that Bruker's second-quarter revenue reached USD 838.50 million, up 5.20 percent from the same quarter a year earlier. Adjusted earnings per share came to USD 0.49, compared with a USD 0.38 consensus estimate, while revenue was below the USD 853.57 million forecast.
That mix gives the November release two clear benchmarks: maintaining the 5.20 percent revenue growth rate and explaining the gap between reported revenue and expectations. The second-quarter adjusted earnings-per-share result exceeded consensus by USD 0.11.
Three dates frame the story
On September 21, 2026, Bruker received a University of California, Berkeley order worth more than USD 6 million, as listed by MarketScreener. On October 14, 2026, Markets Insider reported that JPMorgan downgraded Bruker to Neutral from Overweight while keeping its USD 60.00 price target. On October 20, 2026, Bruker announced its November 4 results date through the release carried by MarketScreener.
What does the Q3 date change?
The next dated catalyst is November 4, 2026, when Bruker plans to discuss third-quarter results and current business trends during an 8:30 a.m. Eastern Daylight Time webcast, according to MarketScreener. For investors, the central comparison will be whether revenue growth and adjusted earnings per share improve on the second-quarter baseline of USD 838.50 million and USD 0.49.
Valuation and trading context
Bruker last stood at USD 57.59 on Nasdaq on October 23, 2026, at 4:00 p.m. ET. Its market capitalization was USD 8.8 billion on that date, and its 52-week range was USD 32.37 to USD 66.98. The further course of trading is shown by the continuously updated real-time quote of Bruker stock.
Bruker stock facts
- Company: Bruker Corporation
- ISIN: US1167941087
- Ticker: BRKR
- Primary exchange: Nasdaq
- Market capitalization: USD 8.8 billion (as of October 23, 2026)
- 52-week range: USD 32.37-66.98 (as of October 23, 2026)
- Sector / Industry: Healthcare / Medical - Devices
- Next earnings date: November 4, 2026
Market context: Market report Nasdaq Composite.
